A phase I, open-label, study of the safety, tolerability, and pharmacokinetics of GW572016 [lapatinib] in combination with paclitaxel in patients with solid tumors
Phase of Trial: Phase I
Latest Information Update: 05 Jun 2007
At a glance
- Drugs Lapatinib (Primary) ; Paclitaxel
- Indications Solid tumours
- Focus Adverse reactions
- 05 Jun 2007 New trial record.